OSE IMMUNOTHERAPEUTICS
Earnings transcripts
- Issuer webcast
02/09/2026 Webcast : Lusvertikimab & the IL-7R Pathway: An Expert Deep Dive into IBD September 2, 2026 – Click here for replay
OSE IMMUNOTHERAPEUTICS
- Issuer webcast
10/06/2026 Webcast : TEDOPI® (KOL event) June 10, 2026 – Click to view the replay
OSE IMMUNOTHERAPEUTICS
- Issuer webcast
28/08/2026 OSE Immunotherapeutics to host a KOL webcast dedicated to lusvertikimab on September 2, 2026
OSE IMMUNOTHERAPEUTICS
- Issuer webcast
2026 investor education transcript
OSE IMMUNOTHERAPEUTICS
- Issuer webcast
Webcast Link
OSE
- Issuer webcast
Rediffusion de notre Webcast du 10 Juin 2026 "TEDOPI®, Most Advanced Therapeutic Cancer Vaccine"
OSE IMMUNOTHERAPEUTICS